Effects of knowledge, education, and experience on acceptance of first trimester screening for chromosomal anomalies

Acta Obstetricia et Gynecologica Scandinavica

Volumn 89, Issue 7, 2010, Pages 931-938

  Stefansdottir, Vigdis ^a,b   Skirton, Heather ^c   Jonasson, Kristjan ^b   Hardardottir, Hildur ^a,b   Jonsson, Jon Johannes ^a,b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

^c UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

Experiential knowledge; Genetic counseling; Patient information; Prenatal screening

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; CHROMOSOME ABERRATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DECISION MAKING; EXPECTANT MOTHER; EXPERIENCE; FEMALE; FIRST TRIMESTER PREGNANCY; GENETIC COUNSELING; HUMAN; ICELAND; KNOWLEDGE; MAJOR CLINICAL STUDY; MATERNAL SERUM; NUCHAL TRANSLUCENCY MEASUREMENT; PATIENT EDUCATION; PRENATAL SCREENING; PRIORITY JOURNAL; QUASI EXPERIMENTAL STUDY; QUESTIONNAIRE; SCORING SYSTEM;

ADULT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMOSOME DISORDERS; FEMALE; GENETIC TESTING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; ICELAND; INTERVENTION STUDIES; MATERNAL HEALTH SERVICES; NUCHAL TRANSLUCENCY MEASUREMENT; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL CARE; PRENATAL DIAGNOSIS; QUESTIONNAIRES; RISK FACTORS;

EID: 77954194852     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.3109/00016341003686073     Document Type: Article

References (33)

1. Steele MW, Breg WR Jr. Chromosome analysis of human amniotic-fluid cells. Lancet. 1966;1:383-385
2. Grant SS. Prenatal genetic screening. Online J Issues Nurs. 2000;5:2.
3. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol. 1984;148:886-894
4. Spencer K. Aneuploidy screening in the first trimester. Am J Med Genet C Semin Med Genet. 2007;145C:18-32.
5. Hardardottir H. Fetal nuchal translucency measurement at 11-13 weeks and risk assessment for fetal aneuploidy and cardiac anomalies. Icelandic Med J. 2001;87:415-421
6. Foundation FM. Fetal Medicine Foundation. 2009. Available online at: http://www.fetalmedicine.com (accessed October 18, 2009).
7. Tiran D. NICE guideline on antenatal care: routine care for the healthy pregnant woman-recommendations on the use of complementary therapies do not promote clinical excellence. Complement Ther Clin Pract. 2005;11:127-129
8. Geirsson RT, Gardarsdóttir G, Palsson G, Bjarnadóttir RI, Hardardóttir H. Skyrsla frá faedingaskráningunni fyrir árid 2006. [Registration of births in Iceland in 2006]. Reykjavik: Landspitali-Haskolasjukrahus [Landspitali University Hospital]. 2006.
9. Kristjansdottir H. Why do pregnant women attend ultrasound screening? Icelandic Med J. 2001;87:47-50.
10. Etchegary H, Potter B, Howley H, Cappelli M, Coyle D, Graham I, et al. The influence of experiential knowledge on prenatal screening and testing decisions. Genet Test. 2008;12:115-124
11. Tercyak KP, Johnson SB, Roberts SF, Cruz AC. Psychological response to prenatal genetic counseling and amniocentesis. Patient Educ Couns. 2001;43:73-84.
12. Browner CH, Press N. The production of authoritative knowledge in American prenatal care. Med Anthropol Q. 1996;10:141-156
13. Santalahti P, Aro AR, Hemminki E, Helenius H, Ryynanen M. On what grounds do women participate in prenatal screening? Prenat Diagn. 1998;18:153-165
14. Kohut RJ, Dewey D, Love EJ. Women's knowledge of prenatal ultrasound and informed choice. J Genet Couns. 2002;11:265-276
15. Massey-Davis L. A woman's right not to choose. Pract Midwife. 1998;1:23-25
16. Spencer K. Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review. Br J Obstet Gynaecol. 1999;106:1287-1293
17. Skirton H, Barr O. Antenatal screening and informed choice: a cross-sectional survey of parents and professionals. Midwifery. 2009; epub ahead of print.
18. Organization WH. Proposed International Guidelines on Ethical Issues in Medical Genetics and Genetic Services (Part II). World Health Organization, Human Genetics Programme. Law Hum Genome Rev. 1998:239-251
19. Ministers Co. Recommendation No. R(92)3 of the Committee of Ministers to member states on genetic testing and screening for health care purposes. J Int Bioethique. 1992;3:255-257
20. Truog RD. Is "informed right of refusal" the same as "informed consent"? J Clin Ethics. 1996;7:87-89
21. Dormandy E, Hooper R, Michie S, Marteau TM. Informed choice to undergo prenatal screening: a comparison of two hospitals conducting testing either as part of a routine visit or requiring a separate visit. J Med Screen. 2002;9:109-114
22. Dormandy E, Michie S, Hooper R, Marteau TM. Informed choice in antenatal Down syndrome screening: a clusterrandomised trial of combined versus separate visit testing. Patient Educ Couns. 2006;61:56-64.
23. Green JM, Hewison J, Bekker HL, Bryant LD, Cuckle HS. Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review. Health Technol Assess. 2004;8:iii, ix-x, 1-109.
24. Gekas J, Gondry J, Mazur S, Cesbron P, Thepot F. Informed consent to serum screening for Down syndrome: are women given adequate information? Prenat Diagn. 1999;19:1-7.
25. van den Berg M, Timmermans DRM, ten Kate LP, van Vugt JMG, van der Wal G. Are pregnant women making informed choices about prenatal screening? Genet Med. 2005;7:332-338
26. Ekelin M, Crang-Svalenius E. Midwives' attitudes to and knowledge about a newly introduced foetal screening method. Scand J Caring Sci. 2004;18:287-293
27. Jaques AM, Bell RJ, Watson L, Halliday JL. People who influence women's decisions and preferred sources of information about prenatal testing for birth defects. Aust NZ J Obstet Gynaecol. 2004;44:233-238
28. Stapleton H, Kirkham M, Thomas G. Qualitative study of evidence based leaflets in maternity care. BMJ. 2002;324:639.
29. Marteau TM, Dormandy E,Michie S. A measure of informed choice. Health Expect. 2001;4:99-108.
30. Muller MA, Bleker OP, Bonse GJ, Bilardo CM. Women's opinions on the offer and use of nuchal translucency screening for Down syndrome. Prenatal Diagnosis. 2006;26:105-111
31. Iceland S. Informational statistics. 2006. Available online at: http://hagstofan.is/ (cited August 30, 2006).
32. Plan on education and science. 2004. Available online at: http://formennska.forsaetisraduneyti.is/Aaetlun/Menntir- ogvisindi (cited December 12, 2006 and January 15, 2009).
33. Thornton JG, Hewison J, Lilford RJ, Vail A. A randomised trial of three methods of giving information about prenatal testing. BMJ. 1995;311:1127-1130